modelling pathogenesis treatment familial dysautonomia using patient-specific ipscs
isolation human induced pluripotent stem cells ipscs- offers new strategy modelling human disease recent studies reported derivation differentiation disease-specific human ipscs- however key challenge field demonstration disease-related phenotypes ability model pathogenesis treatment disease ipscs familial dysautonomia fd rare fatal peripheral neuropathy caused point mutation ikbkap gene involved transcriptional elongation disease characterized depletion autonomic sensory neurons specificity peripheral nervous system mechanism neuron loss fd poorly understood owing lack appropriate model system report derivation patient-specific fd-ipscs directed differentiation cells three germ layers including peripheral neurons gene expression analysis purified fd-ipsc-derived lineages demonstrates tissue-specific mis-splicing ikbkap vitro patient-specific neural crest precursors express particularly low levels normal ikbkap transcript suggesting mechanism disease specificity fd pathogenesis characterized transcriptome analysis cell-based assays revealing marked defects neurogenic differentiation migration behaviour furthermore use fd-ipscs validating potency candidate drugs reversing aberrant splicing ameliorating neuronal differentiation migration study illustrates promise ipsc technology gaining new insights human disease pathogenesis treatment
